Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Ellen BerniHanka de VoogdJulian P J HalcoxChristopher C ButlerChristian A BannisterSara Jenkins-JonesBethan JonesMario OuwensCraig J CurriePublished in: BMJ open (2017)
CV events were more likely after LRTI than after URTI. When analysed by specific indication, CV risk associated with clarithromycin was no different to other antibiotics.